ACM
Aisling Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $617K | Hold |
434,455
| – | – | 0.17% | 11 |
|
|
2025
Q1 | $665K | Hold |
434,455
| – | – | 0.23% | 11 |
|
|
2024
Q4 | $1.08M | Hold |
434,455
| – | – | 0.38% | 12 |
|
|
2024
Q3 | $500K | Hold |
434,455
| – | – | 0.19% | 15 |
|
|
2024
Q2 | $478K | Hold |
434,455
| – | – | 0.21% | 14 |
|
|
2024
Q1 | $539K | Hold |
434,455
| – | – | 0.18% | 15 |
|
|
2023
Q4 | $456K | Hold |
434,455
| – | – | 0.14% | 14 |
|
|
2023
Q3 | $2.98M | Hold |
434,455
| – | – | 1.23% | 9 |
|
|
2023
Q2 | $4.51M | Hold |
434,455
| – | – | 2.21% | 8 |
|
|
2023
Q1 | $3.51M | Hold |
434,455
| – | – | 1.69% | 9 |
|
|
2022
Q4 | $6.84M | Sell |
434,455
-200,000
| -32% | -$3.15M | 4.52% | 5 |
|
|
2022
Q3 | $9.99M | Hold |
634,455
| – | – | 6.63% | 5 |
|
|
2022
Q2 | $8.86M | Hold |
634,455
| – | – | 6.32% | 5 |
|
|
2022
Q1 | $10.9M | Hold |
634,455
| – | – | 5.9% | 6 |
|
|
2021
Q4 | $9.23M | Hold |
634,455
| – | – | 3.25% | 8 |
|
|
2021
Q3 | $11.4M | Hold |
634,455
| – | – | 2.28% | 8 |
|
|
2021
Q2 | $11.1M | Hold |
634,455
| – | – | 1.78% | 10 |
|
|
2021
Q1 | $16M | Hold |
634,455
| – | – | 2.88% | 6 |
|
|
2020
Q4 | $4.11M | Hold |
634,455
| – | – | 0.7% | 11 |
|
|
2020
Q3 | $1.63M | Hold |
634,455
| – | – | 0.52% | 13 |
|
|
2020
Q2 | $1.03M | Hold |
634,455
| – | – | 0.39% | 13 |
|
|
2020
Q1 | $660K | Hold |
634,455
| – | – | 0.29% | 14 |
|
|
2019
Q4 | $1.2M | Hold |
634,455
| – | – | 0.46% | 13 |
|
|
2019
Q3 | $685K | Hold |
634,455
| – | – | 0.36% | 13 |
|
|
2019
Q2 | $1.39M | Hold |
634,455
| – | – | 0.59% | 14 |
|
|
2019
Q1 | $3.8M | Hold |
634,455
| – | – | 2.89% | 11 |
|
|
2018
Q4 | $4.69M | Buy |
+634,455
| New | +$4.69M | 4.94% | 8 |
|